Paperpal Prime Logo

Pharmaceuticals : Impact Factor & More

eISSN: 1424-8247pISSN: 1424-8247
JournalOpen Access

Key Metrics

CiteScore
4
Impact Factor
< 5
Scite Index
0.92 5-Year SI
SNIP
1.22
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Pharmaceuticals

Pharmaceuticals Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher MDPI
Language English
Frequency Monthly
Article Processing ChargesCHF 2200
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2004
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Pharmaceuticals ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Pharmaceuticals

Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization
  • 1 Aug 2026
  • Pharmaceuticals
Exploration of Development Parameters for IgG Microspheres Using an Automated Platform for High-Throughput Formulation Screening
  • 1 Aug 2026
  • Pharmaceuticals
Drug Provocation Tests with Washout Intervals for Delayed Hypersensitivity Reactions: A Real-World Retrospective Analysis
  • 31 Jul 2026
  • Pharmaceuticals
Effect of Formulation and Process Variables on the Stability and Quality Attributes of Digoxin Formulations
  • 29 Jul 2026
  • Pharmaceuticals
Computational and Cellular Evaluation of the Anti-Melanogenic Potential of Gancidin W: Integrating Network Pharmacology and Free-Energy Analyses
  • 29 Jul 2026
  • Pharmaceuticals
RETRACTED: Ibrahim et al. Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity. Pharmaceuticals 2020, 13, 393
  • 27 Jul 2026
  • Pharmaceuticals
Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization
  • 1 Aug 2026
  • Pharmaceuticals
Exploration of Development Parameters for IgG Microspheres Using an Automated Platform for High-Throughput Formulation Screening
  • 1 Aug 2026
  • Pharmaceuticals
Drug Provocation Tests with Washout Intervals for Delayed Hypersensitivity Reactions: A Real-World Retrospective Analysis
  • 31 Jul 2026
  • Pharmaceuticals
Effect of Formulation and Process Variables on the Stability and Quality Attributes of Digoxin Formulations
  • 29 Jul 2026
  • Pharmaceuticals
Computational and Cellular Evaluation of the Anti-Melanogenic Potential of Gancidin W: Integrating Network Pharmacology and Free-Energy Analyses
  • 29 Jul 2026
  • Pharmaceuticals
RETRACTED: Ibrahim et al. Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity. Pharmaceuticals 2020, 13, 393
  • 27 Jul 2026
  • Pharmaceuticals

FAQs on Pharmaceuticals